Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Activity-Based Concept to Screen Biological Matrices for Opiates and (Synthetic) Opioids
Annelies Cannaert, Lakshmi Vasudevan, Melissa Friscia, et al.
Clinical Chemistry (2018) Vol. 64, Iss. 8, pp. 1221-1229
Open Access | Times Cited: 51

Showing 1-25 of 51 citing articles:

Synthesis, Chemical Characterization, and μ-Opioid Receptor Activity Assessment of the Emerging Group of “Nitazene” 2-Benzylbenzimidazole Synthetic Opioids
Marthe M. Vandeputte, Katleen Van Uytfanghe, Nathan K. Layle, et al.
ACS Chemical Neuroscience (2021) Vol. 12, Iss. 7, pp. 1241-1251
Open Access | Times Cited: 96
Report on a novel emerging class of highly potent benzimidazole NPS opioids: Chemical and in vitro functional characterization of isotonitazene
Peter Blanckaert, Annelies Cannaert, Katleen Van Uytfanghe, et al.
Drug Testing and Analysis (2019) Vol. 12, Iss. 4, pp. 422-430
Closed Access | Times Cited: 88
In vitro structure–activity relationships and forensic case series of emerging 2-benzylbenzimidazole ‘nitazene’ opioids
Liam M. De Vrieze, Sara E. Walton, Eline Pottie, et al.
Archives of Toxicology (2024) Vol. 98, Iss. 9, pp. 2999-3018
Open Access | Times Cited: 10
Novel synthetic opioids – toxicological aspects and analysis
Inês Tabarra, Sofia Soares, Tiago Rosado, et al.
Forensic Sciences Research (2019) Vol. 4, Iss. 2, pp. 111-140
Open Access | Times Cited: 58
First identification, chemical analysis and pharmacological characterization of N-piperidinyl etonitazene (etonitazepipne), a recent addition to the 2-benzylbenzimidazole opioid subclass
Marthe M. Vandeputte, Nick Verougstraete, Donna Walther, et al.
Archives of Toxicology (2022) Vol. 96, Iss. 6, pp. 1865-1880
Closed Access | Times Cited: 31
Direct Selection of DNA-Encoded Libraries for Biased Agonists of GPCRs on Live Cells
Bo Cai, Amal El Daibani, Yuntian Bai, et al.
JACS Au (2023) Vol. 3, Iss. 4, pp. 1076-1088
Open Access | Times Cited: 21
In vitro functional characterization of a panel of non-fentanyl opioid new psychoactive substances
Marthe M. Vandeputte, Annelies Cannaert, Christophe P. Stove
Archives of Toxicology (2020) Vol. 94, Iss. 11, pp. 3819-3830
Closed Access | Times Cited: 49
Assessment of structure-activity relationships and biased agonism at the Mu opioid receptor of novel synthetic opioids using a novel, stable bio-assay platform
Lakshmi Vasudevan, Marthe M. Vandeputte, Marie H. Deventer, et al.
Biochemical Pharmacology (2020) Vol. 177, pp. 113910-113910
Open Access | Times Cited: 46
Dual-Acting Small Molecules: Subtype-Selective Cannabinoid Receptor 2 Agonist/Butyrylcholinesterase Inhibitor Hybrids Show Neuroprotection in an Alzheimer’s Disease Mouse Model
Philipp Spatz, Sophie A. M. Steinmüller, Anna Tutov, et al.
Journal of Medicinal Chemistry (2023) Vol. 66, Iss. 9, pp. 6414-6435
Open Access | Times Cited: 14
Luminescence- and Fluorescence-Based Complementation Assays to Screen for GPCR Oligomerization: Current State of the Art
Elise Wouters, Lakshmi Vasudevan, René A. J. Crans, et al.
International Journal of Molecular Sciences (2019) Vol. 20, Iss. 12, pp. 2958-2958
Open Access | Times Cited: 36
In vitro pharmacology of fentanyl analogs at the human mu opioid receptor and their spectroscopic analysis
Sherif H. Hassanien, Jonathon R. Bassman, Carmelita M. Perrien Naccarato, et al.
Drug Testing and Analysis (2020) Vol. 12, Iss. 8, pp. 1212-1221
Open Access | Times Cited: 34
Systematic toxicological analysis in forensic and clinical laboratories: a challenging task of analytical chemistry
Fritz Pragst
ChemTexts (2025) Vol. 11, Iss. 2
Open Access
Assays of DNA-encoded Libraries Against Protein Targets on and Within Living Cells
Siavash Shahbazi Nia, Casey J. Krusemark
Royal Society of Chemistry eBooks (2025), pp. 63-86
Closed Access
Clinical value of analytical testing in patients presenting with new psychoactive substances intoxication
Katharina Elisabeth Grafinger, Matthias E. Liechti, Evangelia Liakoni
British Journal of Clinical Pharmacology (2019) Vol. 86, Iss. 3, pp. 429-436
Open Access | Times Cited: 34
Toxicokinetics and toxicodynamics of the fentanyl homologs cyclopropanoyl-1-benzyl-4´-fluoro-4-anilinopiperidine and furanoyl-1-benzyl-4-anilinopiperidine
Tanja M. Gampfer, Lea Wagmann, Yu Mi Park, et al.
Archives of Toxicology (2020) Vol. 94, Iss. 6, pp. 2009-2025
Open Access | Times Cited: 30
Reporter gene comparison demonstrates interference of complex body fluids with secreted luciferase activity
M. Neefjes, Bas Housmans, Guus van den Akker, et al.
Scientific Reports (2021) Vol. 11, Iss. 1
Open Access | Times Cited: 27
Toxicological and pharmacological characterization of novel cinnamylpiperazine synthetic opioids in humans and in vitro including 2-methyl AP-237 and AP-238
Melissa F. Fogarty, Marthe M. Vandeputte, Alex J. Krotulski, et al.
Archives of Toxicology (2022) Vol. 96, Iss. 6, pp. 1701-1710
Closed Access | Times Cited: 17
Activity-Based Detection and Bioanalytical Confirmation of a Fatal Carfentanil Intoxication
Annelies Cannaert, Lars Ambach, Peter Blanckaert, et al.
Frontiers in Pharmacology (2018) Vol. 9
Open Access | Times Cited: 32
Applications of Protein Fragment Complementation Assays for Analyzing Biomolecular Interactions and Biochemical Networks in Living Cells
Peipei Li, Li Wang, Lijun Di
Journal of Proteome Research (2019) Vol. 18, Iss. 8, pp. 2987-2998
Closed Access | Times Cited: 29
Screening procedure for 38 fentanyl analogues and five other new opioids in whole blood by liquid chromatography‐tandem mass spectrometry
Piotr Adamowicz, Zhanetta Bakhmut, Anna Mikołajczyk
Journal of Applied Toxicology (2020) Vol. 40, Iss. 8, pp. 1033-1046
Closed Access | Times Cited: 27
In vitro functional assays as a tool to study new synthetic opioids at the μ-opioid receptor: Potential, pitfalls and progress
Marthe M. Vandeputte, Lakshmi Vasudevan, Christophe P. Stove
Pharmacology & Therapeutics (2022) Vol. 235, pp. 108161-108161
Open Access | Times Cited: 15
A case report of carfentanil-related fatality in France
Jean‐Michel Gaulier, Camille Richeval, Mélodie Phanithavong, et al.
Annales de Toxicologie Analytique (2019) Vol. 31, Iss. 4, pp. 323-331
Open Access | Times Cited: 23
Novel synthetic opioids: A review of the literature
Sophie La Salle, Sandra Bodeau, Alice Dhersin, et al.
Annales de Toxicologie Analytique (2019) Vol. 31, Iss. 4, pp. 298-316
Closed Access | Times Cited: 23
Systematic evaluation of a panel of 30 synthetic cannabinoid receptor agonists structurally related to MMB‐4en‐PICA, MDMB‐4en‐PINACA, ADB‐4en‐PINACA, and MMB‐4CN‐BUTINACA using a combination of binding and different CB1 receptor activation assays. Part III: The G protein pathway and critical comparison of different assays
Katharina Elisabeth Grafinger, Marthe M. Vandeputte, Annelies Cannaert, et al.
Drug Testing and Analysis (2021) Vol. 13, Iss. 7, pp. 1412-1429
Open Access | Times Cited: 19
Activity-based reporter assays for the screening of abused substances in biological matrices
Annelies Cannaert, Marthe M. Vandeputte, Sarah M.R. Wille, et al.
Critical Reviews in Toxicology (2019) Vol. 49, Iss. 2, pp. 95-109
Closed Access | Times Cited: 19
Page 1 - Next Page

Scroll to top